Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Thorax

• Publication date

  2004-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.2003.014258PMID 15047956PMCID PMC1763796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).

  2004cited by this paper
• Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa

  2002cited by this paper
• Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa

  2002cited by this paper
• Use of Subtractive Hybridization To Identify a Diagnostic Probe for a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa

  2002cited by this paper
• Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

  2001cited by this paper
• Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

  2001cited by this paper
• Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.

  2001cited by this paper
• Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.

  1997cited by this paper
• Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

  1996cited by this paper
• Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic

  1996cited by this paper
• Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa

  1995cited by this paper
• Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients

  1993cited by this paper
• Antibiotic treatment of cystic fibrosis.

  1981cited by this paper
• Hospital-acquired infections.

  1975cited by this paper
• Hospital-acquired infections.

  1970cited by this paper

• Antimicrobial resistance in chronic lung infection: the road to resistance

  2025cites this paper
• МУКОВИСЦИДОЗ КАК КОМПЛЕКСНАЯ ПРОБЛЕМА ГЕНЕТИКИ, МИКРОБИОЛОГИИ, ПЕДИАТРИИ И ХИРУРГИИ

  2025cites this paper
• Evolutionary Adaptation of KPC-2-Producing Pseudomonas aeruginosa High-Risk Sequence Type 463 in a Lung Transplant Patient.

  2024cites this paper
• Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivo

  2024cites this paper
• A population-level strain genotyping method to study pathogen strain dynamics in human infections

  2021cites this paper
• Pathways, Practices and Architectures: Containing Anti-Microbial Resistance (AMR) in the Cystic Fibrosis Clinic

  2021cites this paper
• Transmission, adaptation and geographical spread of the Pseudomonas aeruginosa Liverpool epidemic strain

  2021cites this paper
• Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation

  2021cites this paper
• Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening.

  2021cites this paper
• Label‐free quantitative proteomics identifies unique proteomes of clinical isolates of the Liverpool Epidemic Strain of Pseudomonas aeruginosa and laboratory strain PAO1

  2021cites this paper
• Estimation of pathogenic potential of an environmental Pseudomonas aeruginosa isolate using comparative genomics

  2020cites this paper
• Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities

  2020cites this paper
• Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58

  2020cites this paper
• Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross‐infections

  2020cites this paper
• Pathways, practices and architectures: Containing antimicrobial resistance in the cystic fibrosis clinic

  2019cites this paper
• Bacteriophage Moron JBD30-4 Affects type IV pilus and Flagellar Function in Pseudomonas aeruginosa

  2019cites this paper
• Pediatric Pulmonology

  2019influential citation
• Within-Host Fine-Scale Evolutionary Dynamics of Infectious Bacterial Populations

  2019cites this paper
• Microbiology of the Cystic Fibrosis Airway

  2019cites this paper
• Infection prevention and control in cystic fibrosis: a systematic review of interventions

  2019cites this paper
• Genetic deletion of Sphk2 confers protection against Pseudomonas aeruginosa mediated differential expression of genes related to virulent infection and inflammation in mouse lung

  2019cites this paper
• Role of PA 3574 ( nalD ) gene in development of ciprofloxacin resistance in Pseudomonas aeruginosa isolates

  2019cites this paper
• Population structure of Pseudomonas aeruginosa through a MLST approach and antibiotic resistance profiling of a Mexican clinical collection.

  2018cites this paper
• Edinburgh Research Explorer Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens

  2018cites this paper
• Pseudomonas-Specific NGS Assay Provides Insight Into Abundance and Dynamics of Pseudomonas Species Including P. aeruginosa in a Cooling Tower

  2018cites this paper
• Genomic Island Discovery through Enrichment of Statistical Modeling with Biological Information

  2018cites this paper
• of The

  2018cites this paper
• Assessment of Pseudomonas aeruginosa epidemiology and the wider microbial diversity within the bronchiectatic lung

  2018cites this paper
• Work environment risks for health care workers with cystic fibrosis

  2018cites this paper
• Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population

  2018cites this paper
• Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics

  2018cites this paper
• Phenotypic and molecular characterisation of Pseudomonas aeruginosa infections from companion animals and potential reservoirs of antibacterial resistance in humans.

  2018influential citation
• Elimination of Australian epidemic strain (AES1) pseudomonas aeruginosa in a pediatric cystic fibrosis center

  2018cites this paper
• Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre

  2018cites this paper
• Role of PA3574 (nalD) gene in development of ciprofloxacin resistance in Pseudomonas aeruginosa isolates

  2018cites this paper
• Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series.

  2018cites this paper
• Étude de la virulence et de la formation de biofilms chez Pseudomonas aeruginosa

  2018cites this paper
• Examining the Distribution of the Extracellular Polymeric Substances in the Biofilms of the Liverpool Epidemic Strain of Pseudomonas aeruginosa

  2018cites this paper
• Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis

  2018influential citation
• Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain

  2018cites this paper
• Andrée-Ann and Jeukens , Julie and Kukavica-Ibrulj ,

  2018cites this paper
• Comparative genomics of Pseudomonas aeruginosa populations

  2017cites this paper
• ACCURATE IN VITRO METHODS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF BACTERIAL PATHOGENS

  2017cites this paper
• Chasing Zero: Increasing Infection Control Compliance on an Inpatient Cystic Fibrosis Unit

  2017cites this paper
• Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection

  2017cites this paper
• Pseudomonas Endocarditis with an unstable phenotype: the challenges of isolate characterization and Carbapenem stewardship with a partial review of the literature

  2017cites this paper
• The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.

  2017cites this paper
• Proteogenomics of Pseudomonas aeruginosa in Cystic Fibrosis Infections

  2017cites this paper
• Combating Pseudomonas aeruginosa lung infections using synthetic host defense peptides

  2017cites this paper
• Mechanisms of acid and base secretion: implications for airway host defense in cystic fibrosis

  2017cites this paper
• High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections

  2017cites this paper
• RAPD- and ERIC-Based Typing of Clinical and Environmental Pseudomonas aeruginosa Isolates.

  2017cites this paper
• Aminoglycoside-induced nephrotoxicity in children

  2016cites this paper
• The clinical development of antibiotics with a new mode of action combined with efficient pulmonary 21 drug delivery is a priority against untreatable Pseudomonas aeruginosa lung infections

  2016influential citation
• Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy

  2016cites this paper
• Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung Infections.

  2016cites this paper
• Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis

  2016cites this paper
• Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia

  2016influential citation
• Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation.

  2016cites this paper
• Identification of Novel Genomic Islands in Liverpool Epidemic Strain of Pseudomonas aeruginosa Using Segmentation and Clustering

  2016cites this paper
• Investigations to underpin the development of bacteriophages as therapeutic agents to target pseudomonas aeruginosa infections in patients with cystic fibrosis

  2016influential citation
• Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.

  2016cites this paper
• Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration

  2016cites this paper
• The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients

  2016cites this paper
• Long-term clinical outcomes of ‘Prairie Epidemic Strain’ Pseudomonas aeruginosa infection in adults with cystic fibrosis

  2016cites this paper
• The increasing threat of Pseudomonas aeruginosa high-risk clones.

  2015cites this paper
• Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis

  2015cites this paper
• Impact of pseudomonas aeruginosa Liverpool epidemic strain (LES) on cystic fibrosis patients

  2015cites this paper
• Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections.

  2015cites this paper
• Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung

  2015cites this paper
• Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa

  2015cites this paper
• Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients

  2015cites this paper
• Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis

  2015cites this paper
• Bactericidal Activities of Cathelicidin LL-37 and Select Cationic Lipids against the Hypervirulent Pseudomonas aeruginosa Strain LESB58

  2015cites this paper
• The role of prophages in Pseudomonas aeruginosa

  2015cites this paper
• - Microbiology of cystic fibrosis: Epidemiology of cystic fibrosis pathogens and clinical microbiology laboratory methods

  2015cites this paper
• Effect of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis.

  2015cites this paper
• Genotyping of Pseudomonas aeruginosa reveals high diversity, stability over time and good outcome of eradication.

  2015cites this paper
• Chronic Pseudomonas aeruginosa Infection and Respiratory Muscle Impairment in Cystic Fibrosis

  2014cites this paper
• Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting

  2014cites this paper
• Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs

  2014cites this paper
• Infections in Patients with Cystic Fibrosis

  2014cites this paper
• Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

  2014cites this paper
• Improved patient safety through reduced airway infection rates in a paediatric cystic fibrosis programme after a quality improvement effort to enhance infection prevention and control measures

  2014cites this paper
• Current concepts: host–pathogen interactions in cystic fibrosis airways disease

  2014cites this paper
• Genome-Wide Patterns of Recombination in the Opportunistic Human Pathogen Pseudomonas aeruginosa

  2014cites this paper
• Model of Chronic Lung Infection the Hypervirulent Strain LESB58 in a Rat Strains PAO1 and PA14 and aeruginosa Pseudomonas In Vivo Growth of

  2014cites this paper
• Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

  2014cites this paper
• Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.

  2014cites this paper
• Infection with the Houston-1 Strain and Determination of Risk Factors for Population of Patients with Cystic Fibrosis aeruginosa Isolates in a Pediatric Multidrug-Resistant Pseudomonas Molecular Epidemiological Surveillance of

  2014cites this paper
• Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections

  2014cites this paper
• The role of respiratory viruses in exacerbations of cystic fibrosis in adults

  2014cites this paper
• Airborne dissemination of transmissible bacterial species in cystic fibrosis

  2014cites this paper
• pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study

  2013cites this paper
• Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis

  2013cites this paper
• Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium

  2013cites this paper
• Developing an international Pseudomonas aeruginosa reference panel

  2013cites this paper
• Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study

  2013cites this paper
• Molecular Epidemiological Surveillance of Multidrug-Resistant Pseudomonas aeruginosa Isolates in a Pediatric Population of Patients with Cystic Fibrosis and Determination of Risk Factors for Infection with the Houston-1 Strain

  2013cites this paper
• Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients.

  2013cites this paper